Long pages

Showing below up to 50 results in range #301 to #350.

301. (hist) ‎Vertigo ‎[6,512 bytes]
302. (hist) ‎Tachyarrhythmia ‎[6,479 bytes]
303. (hist) ‎Chronic pancreatitis ‎[6,463 bytes]
304. (hist) ‎56. Opioid analgesic drugs. Semisynthetic, synthetic opioids, opioid antagonists ‎[6,461 bytes]
305. (hist) ‎Pancreatic cancer ‎[6,413 bytes]
306. (hist) ‎24. Classification of hemorrhages based on pathomechanism ‎[6,388 bytes]
307. (hist) ‎18. Adrenergic receptor antagonists (alpha blockers and beta blockers) ‎[6,381 bytes]
308. (hist) ‎23. Definition of edema, pathomechanism (Starling law), clinical forms ‎[6,379 bytes]
309. (hist) ‎Gastrointestinal bleeding ‎[6,362 bytes]
310. (hist) ‎25. Thrombosis and embolus. Definitions, causes, types and clinical consequences ‎[6,350 bytes]
311. (hist) ‎Liver cancer ‎[6,313 bytes]
312. (hist) ‎Coagulation tests ‎[6,310 bytes]
313. (hist) ‎29. Protein deficiency. Protein-calorie malnutrition. Senile sarcopenia ‎[6,296 bytes]
314. (hist) ‎40. Hyperglycemia and glucose-tolerance tests. Diagnosis of diabetes mellitus. ‎[6,294 bytes]
315. (hist) ‎30. Definition, causes, cellular and humoral mechanisms of chronic inflammation ‎[6,282 bytes]
316. (hist) ‎11. Amino acid metabolism; the fate of the amino group ‎[6,269 bytes]
317. (hist) ‎14. Synthesis of non-essential amino acids ‎[6,251 bytes]
318. (hist) ‎B16. The mechanism and the prevention of Rh-isoimmunisation, erythroblastosis fetalis ‎[6,250 bytes]
319. (hist) ‎51. Partial or complete respiratory failure ‎[6,228 bytes]
320. (hist) ‎20. Hypersensitivity ‎[6,225 bytes]
321. (hist) ‎4. The neuromuscular junction ‎[6,217 bytes]
322. (hist) ‎42. Disorders of the control of breathing. Age-dependent changes. Sleep-apnea syndrome ‎[6,216 bytes]
323. (hist) ‎18. Causes of atrophy; general gross morphology and microscopical characteristics. Pathomechanism of atrophy. Hypoplasia, aplasia, agenesia. Osteoporosis. ‎[6,215 bytes]
324. (hist) ‎B5. Intersexuality, gonadal dysgenesis ‎[6,203 bytes]
325. (hist) ‎24. Benign and malignant nephrosclerosis and diffuse cortical necrosis. Urolithiasis and obstructive uropathy. ‎[6,199 bytes]
326. (hist) ‎Respiratory failure ‎[6,189 bytes]
327. (hist) ‎42. General pathobiochemistry of diabetes mellitus syndrome ‎[6,188 bytes]
328. (hist) ‎Pneumothorax ‎[6,155 bytes]
329. (hist) ‎22. Prevention of infectious diseases: vaccination, chemoprophylaxis ‎[6,153 bytes]
330. (hist) ‎Human immunodeficiency virus and acquired immunodeficiency syndrome ‎[6,149 bytes]
331. (hist) ‎A14. Hormonal contraception; indications, contraindications, positive effects and potential complications ‎[6,132 bytes]
332. (hist) ‎21. Drugs acting on the renin-angiotensin-aldosterone system ‎[6,123 bytes]
333. (hist) ‎B2. Conception, implantation ‎[6,121 bytes]
334. (hist) ‎Acute coronary syndrome ‎[6,118 bytes]
335. (hist) ‎Alcoholic liver disease ‎[6,114 bytes]
336. (hist) ‎Nephrotic syndrome ‎[6,094 bytes]
337. (hist) ‎14. Muscarinic receptor antagonists ‎[6,062 bytes]
338. (hist) ‎1 – Introduction, gait cycle, symptoms in orthopaedic disorders ‎[6,061 bytes]
339. (hist) ‎Paraneoplastic syndrome ‎[6,054 bytes]
340. (hist) ‎Potassium ‎[6,054 bytes]
341. (hist) ‎Acute kidney injury ‎[6,050 bytes]
342. (hist) ‎23. Malformations of the nervous system ‎[6,050 bytes]
343. (hist) ‎22. Cerebral hypoxia, ischaemia, stroke ‎[6,046 bytes]
344. (hist) ‎Hypokalaemia ‎[6,033 bytes]
345. (hist) ‎2. Molecular components of the immune systems ‎[6,032 bytes]
346. (hist) ‎2. Role of nutrition in prevention of cancers ‎[6,027 bytes]
347. (hist) ‎Acute urinary retention ‎[6,025 bytes]
348. (hist) ‎23. Physical activity, inactivity, immobilization syndrome. Factors from lifestyle and age ‎[6,013 bytes]
349. (hist) ‎61. Mastitides (lactational, ductus ectasia, fat necrosis, galactocele). Mastopathies (fibrocystic change). Fibroepthelial tumours. ‎[6,008 bytes]
350. (hist) ‎Chronic obstructive pulmonary disease ‎[5,998 bytes]